These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26116540)

  • 1. TGF-β1-induced regulatory T cells.
    Hadaschik EN; Enk AH
    Hum Immunol; 2015 Aug; 76(8):561-4. PubMed ID: 26116540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis: Ag-specific regulatory T cells are more potent suppressors than polyclonal regulatory T cells.
    Huter EN; Stummvoll GH; DiPaolo RJ; Glass DD; Shevach EM
    Int Immunopharmacol; 2009 May; 9(5):540-5. PubMed ID: 19539565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M; Chen W; Stepkowski SM
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of induced versus natural regulatory T cells of the same TCR specificity for induction of tolerance to an environmental antigen.
    Huang H; Ma Y; Dawicki W; Zhang X; Gordon JR
    J Immunol; 2013 Aug; 191(3):1136-43. PubMed ID: 23817420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of TGF-β(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo.
    Tu CX; Jin WW; Lin M; Wang ZH; Man MQ
    Arch Dermatol Res; 2011 Nov; 303(9):685-9. PubMed ID: 21644048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells.
    Ahmadzadeh M; Rosenberg SA
    J Immunol; 2005 May; 174(9):5215-23. PubMed ID: 15843517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced CD4+ forkhead box protein-positive T cells inhibit mast cell function and established contact hypersensitivity through TGF-β1.
    Su W; Fan H; Chen M; Wang J; Brand D; He X; Quesniaux V; Ryffel B; Zhu L; Liang D; Zheng SG
    J Allergy Clin Immunol; 2012 Aug; 130(2):444-52.e7. PubMed ID: 22738679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
    Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
    Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolic acid-treated dendritic cells generate regulatory CD4+ T cells that suppress CD8+ T cells' allocytotoxicity.
    Kazma I; Lemoine R; Herr F; Chadet S; Meley D; Velge-Roussel F; Lebranchu Y; Baron C
    Int Immunol; 2014 Mar; 26(3):173-81. PubMed ID: 24222014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β-Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism.
    Xu A; Liu Y; Chen W; Wang J; Xue Y; Huang F; Rong L; Lin J; Liu D; Yan M; Li QZ; Li B; Song J; Olsen N; Zheng SG
    J Immunol; 2016 May; 196(9):3631-41. PubMed ID: 27001954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
    Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX
    Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1-dependent immune regulation by transforming growth factor-β2-exposed antigen-presenting cells.
    Mir FA; Contreras-Ruiz L; Masli S
    Immunology; 2015 Dec; 146(4):547-56. PubMed ID: 26458493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.
    Mantel PY; Kuipers H; Boyman O; Rhyner C; Ouaked N; Rückert B; Karagiannidis C; Lambrecht BN; Hendriks RW; Crameri R; Akdis CA; Blaser K; Schmidt-Weber CB
    PLoS Biol; 2007 Dec; 5(12):e329. PubMed ID: 18162042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectin-like receptor Ly49s3 on dendritic cells contributes to the differentiation of regulatory T cells in the rat thymus.
    Yamada T; Nanashima N; Akita M; Shimizu T; Miura T; Yamana D; Sawano T; Sakurai T; Tsuchida S
    J Immunol; 2013 Oct; 191(7):3799-809. PubMed ID: 23997226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
    Prud'homme GJ; Piccirillo CA
    J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.
    Gunnlaugsdottir B; Maggadottir SM; Skaftadottir I; Ludviksson BR
    Scand J Immunol; 2013 Feb; 77(2):125-34. PubMed ID: 23126599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
    Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
    J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.